Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced the convening of its second extraordinary general meeting (EGM) in 2025, scheduled for September 26. Key resolutions to be considered include amendments to the company’s Articles of Association, the dissolution of the Supervisory Committee, changes to the Rules of Procedures for Shareholders’ Meetings and the Board of Directors, and the election of a new executive director. These resolutions, if passed, could impact the company’s governance structure and operational procedures.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company with limited liability established in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products.
Average Trading Volume: 1,799,334
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.52B
Learn more about 0874 stock on TipRanks’ Stock Analysis page.